NanoFuse bioactive glass–demineralized bone matrix composite was found to be stronger than DBM alone or bioactive glass alone, according to a study in the International Journal of Spine Surgery. Researchers examined whether combining DBM and bioactive glass could produce a…
Biologics
Kolosis Bio and nonprofit MTF Biologics are launching Summit Matrix, a synthetic bone graft for spine and orthopedic surgeries. The bone graft is supported by NanoLift surface technology and designed to improve bone regeneration, according to a Jan. 14 news…
Tetrous earned a U.S. patent related to its EnFix family of demineralized cortical bone fiber implants, according to a Jan. 13 news release. The new patent protects the application of EnFix DBF technology for enthesis reformation. The platform leverages a…
Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release. B3 Gel is a collagen-based tissue protector derived from extracellular matrix and…
Here are four updates in spine and orthopedic biologics since Nov. 6. 1. Xtant Medical’s CollagenX wound healing product is out in a full commercial launch. CollagenX can be used by cases that Xtant Medical’s spine and orthopedics biologics portfolio…
Advertisement
A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than a local autograft, according to a Dec. 17 news release. Five things to know: 1. The controlled IDE study included…
Xtant Medical released its nanOss Strata synthetic bone graft in a commercial launch, according to a Dec. 11 news release. The bone graft is manufactured from hydroxycarbonapatite, which is more soluble than traditional hydroxyapatite. The bone graft is designed to…
The American Academy of Orthopaedic Surgeons has established the AAOS Orthobiologics Registry to measure the long-term safety, efficacy and outcomes, according to a Dec. 5 news release. The registry is designed to collect data for orthobiologics therapies for patients with…
For its groundbreaking work in sustaining global health systems in a year of geopolitical turbulence, Xenco Medical has been awarded the prestigious Excellence in Governance and Leadership for Global Challenges Award by the World Economic Forum for its role in…
Spine biologics companies are navigating unprecedented commercial pressure and accelerating technological change. As demand for regenerative solutions grows and competition intensifies, leaders are forming strategic partnerships to strengthen distribution channels, advance product pipelines and meet surgeon expectations. The pace of…